These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24735159)
1. 2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics. Lindsley CW ACS Chem Neurosci; 2014 Apr; 5(4):250-1. PubMed ID: 24735159 [No Abstract] [Full Text] [Related]
2. The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots. Lindsley CW ACS Chem Neurosci; 2013 Jun; 4(6):905-7. PubMed ID: 24024784 [No Abstract] [Full Text] [Related]
3. 2014 global prescription medication statistics: strong growth and CNS well represented. Lindsley CW ACS Chem Neurosci; 2015 Apr; 6(4):505-6. PubMed ID: 25873191 [No Abstract] [Full Text] [Related]
4. 2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions. Lindsley CW ACS Chem Neurosci; 2013 Aug; 4(8):1133-5. PubMed ID: 23962293 [No Abstract] [Full Text] [Related]
5. The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing. Lindsley CW ACS Chem Neurosci; 2010 Jun; 1(6):407-8. PubMed ID: 22778834 [No Abstract] [Full Text] [Related]
6. 2013 trends and statistics for prescription medications in the United States: CNS highest ranked and record number of prescriptions dispensed. Lindsley CW ACS Chem Neurosci; 2015 Mar; 6(3):356-7. PubMed ID: 25783498 [No Abstract] [Full Text] [Related]
7. Drugmakers plow more resources into autism. Sheridan C Nat Biotechnol; 2013 May; 31(5):367-9. PubMed ID: 23657371 [No Abstract] [Full Text] [Related]
8. Promotion of prescription drugs to consumers and providers, 2001-2010. Kornfield R; Donohue J; Berndt ER; Alexander GC PLoS One; 2013; 8(3):e55504. PubMed ID: 23469165 [TBL] [Abstract][Full Text] [Related]
14. [Supply shortages of drugs - a global problem]. Bruhn C Dtsch Med Wochenschr; 2012 Aug; 137(34-35):1676-7. PubMed ID: 23066532 [No Abstract] [Full Text] [Related]
15. Sticker shock sharpens focus on biologics. McNeil C J Natl Cancer Inst; 2007 Jun; 99(12):910-2, 914. PubMed ID: 17565148 [No Abstract] [Full Text] [Related]
16. Oncology business development global summit. Bockman JM; Nalam S IDrugs; 2005 Jan; 8(1):37-40. PubMed ID: 15650940 [No Abstract] [Full Text] [Related]
17. Market uptake of biologic and small-molecule--targeted oncology drugs in Europe. Obradovic M; Mrhar A; Kos M Clin Ther; 2009 Dec; 31(12):2940-52. PubMed ID: 20110034 [TBL] [Abstract][Full Text] [Related]
18. [Price of medications: the actual system must be seen again]. Mayencourt J Rev Med Suisse; 2016 Mar; 12(508):479. PubMed ID: 27089613 [No Abstract] [Full Text] [Related]
19. Discounted drug prices for hospitals: result in prescriptions for expensive drugs in the community. Prescrire Int; 2015 Sep; 24(163):223. PubMed ID: 26417639 [TBL] [Abstract][Full Text] [Related]
20. US drug industry group launches campaign to defend pricing. McCarthy M BMJ; 2016 Sep; 354():i4902. PubMed ID: 27612867 [No Abstract] [Full Text] [Related] [Next] [New Search]